Researcher.Life Logo

UCJC Business and Society Review : Impact Factor & More

eISSN: 2659-3270pISSN: 1698-5117
JournalOpen Access

Key Metrics

CiteScore
0.7
SJR
Q4Finance
SNIP
0.26
Recommended pre-submission checks
Powered by Paperpal by Editage

UCJC Business and Society Review Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher UNIV CAMILO JOSE CELA
Language English,Spanish
Frequency Quarterly
Publication Time10
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish,Spanish
FrequencyQuarterly
Publication Start Year2018
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in UCJC Business and Society Review

Evolving role of biomarkers in spinal cord injury: From research to clinical translation.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism
  • 1 Jun 2026
  • Biomedicine & Pharmacotherapy
Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity
  • 1 Jun 2026
  • Biomedicine & Pharmacotherapy
PEG-PCL nanoparticles loaded with amazonian compounds inhibit Zika virus replication and modulate host immune responses.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Variant-dependent pharmacological rescue of phenylalanine hydroxylase supports a precision therapeutic strategy for phenylketonuria.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Early-stage antidiabetic potential of hemp seed hull-derived Cannabisins A, B, and F: Integrated computational and experimental evidence for intestinal α-glucosidase inhibition and incretin modulation.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Evolving role of biomarkers in spinal cord injury: From research to clinical translation.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism
  • 1 Jun 2026
  • Biomedicine & Pharmacotherapy
Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity
  • 1 Jun 2026
  • Biomedicine & Pharmacotherapy
PEG-PCL nanoparticles loaded with amazonian compounds inhibit Zika virus replication and modulate host immune responses.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Variant-dependent pharmacological rescue of phenylalanine hydroxylase supports a precision therapeutic strategy for phenylketonuria.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Early-stage antidiabetic potential of hemp seed hull-derived Cannabisins A, B, and F: Integrated computational and experimental evidence for intestinal α-glucosidase inhibition and incretin modulation.
  • 1 Jun 2026
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

FAQs on UCJC Business and Society Review